AstraZeneca publishes stock exchange announcements via London Stock Exchange
Pharmaceutical company AstraZeneca has notified its announcements to the London Stock Exchange through the Regulatory News Service. These announcements concern official disclosures related to the company's stock trading.
Pharmaceutical firm AstraZeneca has stated that all official announcements are made through the London Stock Exchange's Regulatory News Service. These notifications pertain to regulatory disclosures concerning the company's stock trading and investor relations.
The company directs media and investors to these official channels for real-time information. AstraZeneca clarifies that its website serves as a gateway to these official stock exchange announcements, rather than containing new disclosures itself.
AstraZeneca also warns that archival material referencing its products should not be used for clinical purposes, as it may not reflect current medical knowledge. Stakeholders are advised to consult the official stock exchange notifications for the most up-to-date and accurate information regarding the company and its products.